Pvg Asset Management »

Avadel Pharmaceuticals shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $358k 34k 10.51

More positions owned by Pvg Asset Management

Vanguard Index S&P 500 Etf (VOO)
Anavex Life Sciences (AVXL)
S&p 500 Indx Etf (IVV)
NVIDIA Corporation (NVDA)
Journey Med Corp (DERM)
Amazon (AMZN)
Broadcom (AVGO)
Blackrock Enhanced Equity Div Trust Etf (BDJ)
Microsoft Corporation (MSFT)
Short QQQ ProShares Etf (PSQ)
Veru
Boeing Company (BA)
JP Morgan Premium Income ETF Etf (JEPI)
Neos ETF Trust S&P 500 High Income Etf (SPYI)
Grail (GRAL)

View all positions for Pvg Asset Management

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Vanguard Group
Brandes Investment Partners
Two Seas Capital
Jeffrey L. Gendell
Polar Capital Holdings
Vivo Capital
State Street Corporation
Geode Capital Management
Tang Capital Management
Susquehanna International
Wealth Effects
Kennedy Capital Management
Citadel Advisors

View all funds holding Avadel Pharmaceuticals